Efek Nefroprotektif Nanoemulsi Kulit Jeruk (Citrus Reticularis) dan Aloe Vera: Studi pada Tikus Model Nefropati Diabetik Terinduksi Uninefrektomi dan Streptozotocin

Dede Syifa Izzatul Aulia; Mutia Fudhla Karima; Ridha Syifaa Ar-Rahiim; Evy Sulistyoningrum

doi:10.55606/jurrikes.v5i1.7712

Authors

Dede Syifa Izzatul Aulia Universitas Islam Indonesia
Mutia Fudhla Karima Universitas Islam Indonesia
Ridha Syifaa Ar-Rahiim Universitas Islam Indonesia
Evy Sulistyoningrum Universitas Islam Indonesia

DOI:

https://doi.org/10.55606/jurrikes.v5i1.7712

Keywords:

Aloe Vera, Citrus Peel, Diabetic Nephropathy, Glomerulus, Nephroprotective

Abstract

Diabetic nephropathy is a chronic complication resulting from hyperglycemia, which triggers oxidative stress and inflammation, leading to progressive structural and functional kidney damage. Orange peel and Aloe vera contain bioactive compounds with antioxidant and antifibrotic properties that may protect the kidneys from diabetes induced injury. Nanoemulsion delivery systems can enhance the bioavailability of these extracts in the body. This experimental study aimed to analyze the nephroprotective effects of orange peel and Aloe vera nanoemulsion in a diabetic nephropathy rat model, including glomerular morphology and kidney function. A post-test only control group design was used on Wistar rats divided into five groups: positive control, negative control, and three treatment groups receiving varying nanoemulsion doses. Glomerular structure was evaluated by assessing the number of glomeruli exhibiting synechiae and analyzed using the Kruskal–Wallis test due to non-normal data distribution, yielding p=0.2387 (p>0.05), indicating no significant differences among groups. Urea levels were elevated above normal, whereas creatinine levels remained within normal limits. Although not statistically significant, the treatment groups demonstrated nephroprotective tendencies, shown by improvements in glomerular synechiae in the diabetic nephropathy model.

Downloads

Download data is not yet available.

References

Agarwal, R. (2021). Pathogenesis of Diabetic Nephropathy. ADA Clinical Compendia, 2021(1), 2–7.

https://doi.org/10.2337/db20211-2

Antar, S. A., Abdo, W., Taha, R. S., Farage, A. E., El-Moselhy, L. E., Amer, M. E., & Mahmoud, A. M. (2022). Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sciences, 291, 120260.

https://doi.org/10.1016/j.lfs.2021.120260

Arif, T., Pitoyo, J., & Sudjarwo, E. (2022). The Effect of Aloe Vera Extract on Blood Glucose Levels in Streptozotocin-Induced Rats. Jurnal Ners Dan Kebidanan (Journal of Ners and Midwifery), 9(2), 178–185.

https://doi.org/10.26699/jnk.v9i2.ART.p178-185

Arora, M. K., Sarup, Y., Tomar, R., Singh, M., & Kumar, P. (2019). Amelioration of Diabetes-Induced Diabetic Nephropathy by Aloe vera: Implication of Oxidative Stress and Hyperlipidemia. Journal of Dietary Supplements, 16(2), 227–244.

https://doi.org/10.1080/19390211.2018.1449159

Bawono, Y. D., Samsol, & Ristawati, A. (2023). Analisis Penggunaan Kulit Jeruk Sebagai Additive Surfaktan Terhadap Recovery Factor Dengan Metode Coreflood. PETRO: Jurnal Ilmiah Teknik Perminyakan, 11(4), 157–162.

https://doi.org/10.25105/petro.v11i4.13292

Charan, J., Kaur, R., Bhardwaj, P., Singh, K., Ambwani, S. R., & Misra, S. (2021). Sample Size Calculation in Medical Research: A Primer. Annals of the National Academy of Medical Sciences (India), 57, 74.

https://doi.org/10.1055/s-0040-1722104

Deora, N., & Venkatraman, K. (2022). Aloe vera in diabetic dyslipidemia: Improving blood glucose and lipoprotein levels in pre-clinical and clinical studies. Journal of Ayurveda and Integrative Medicine, 13(4), 100675.

https://doi.org/10.1016/j.jaim.2022.100675

Depari, S. A. F., Rambe, D. J. A., Meilando, R., Lisya, C., Mutia, M. S., & Lubis, Y. E. P. (2021). Uji Efektivitas Ekstrak Etanol Kulit Jeruk Sunkist (Citrus Sinensis (L.) Osbeck) Terhadap Kadar Gula Darah Tikus Wistar (Rattus Norvegicus) Dengan Hiperkolesterolemia Yang Diinduksi Streptozotocin. Biospecies, 14(1), 1–9.

https://doi.org/10.22437/biospecies.v14i1.11250

Dwiyatna, N. I., Erianti, S., & Wisanti, E. (2022). Gambaran penanganan hipoglikemia yang dilakukan keluarga pada pasien diabetes mellitus. Jurnal Keperawatan Abdurrab, 6(1), 38–48.

https://doi.org/10.36341/jka.v6i1.2183

Efiong, E. E., Effa, E., Peters, E., Erukainure, O. L., Amadi, P. U., Ikebuiro, J. O., … Grallert, H. (2025). Multi-Target Modulation of Polyphenols in Diabetic Kidney Disease Therapeutics: A Comprehensive Review. Food Science & Nutrition, 13(10).

https://doi.org/10.1002/fsn3.70882

Elmoghayer, M. E., Saleh, N. M., & Abu Hashim, I. I. (2024). Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study. Drug Delivery and Translational Research, 14(4), 895–917.

https://doi.org/10.1007/s13346-023-01440-6

Herman, T. F., & Santos, C. (2023). First-Pass Effect. Treasure Island: StatPearls Publishing. Retrieved from

https://www.ncbi.nlm.nih.gov/books/NBK551679/

Hoogeveen, E. K. (2022). The Epidemiology of Diabetic Kidney Disease. Kidney and Dialysis, 2(3), 433–442.

https://doi.org/10.3390/kidneydial2030038

Mengstie, M. A., Chekol Abebe, E., Behaile Teklemariam, A., Tilahun Mulu, A., Agidew, M. M., Teshome Azezew, M., … Agegnehu Teshome, A. (2022). Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications. Frontiers in Molecular Biosciences, 9.

https://doi.org/10.3389/fmolb.2022.1002710

Munir, H., Yaqoob, S., Awan, K. A., Imtiaz, A., Naveed, H., Ahmad, N., & Ma, Y. (2024). Unveiling the Chemistry of Citrus Peel: Insights into Nutraceutical Potential and Therapeutic Applications. Foods, 13(11), 1681.

https://doi.org/10.3390/foods13111681

Mustafidah, R., Asyari, R. P., Velayati, J. M., & Sayekti, T. (2022). Pemanfaatan Limbah Kulit Jeruk sebagai Fortifikan Guna Memperkaya Nilai Gizi pada Cokelat. Jurnal Tadris IPA Indonesia, 2(2), 121–130.

https://doi.org/10.21154/jtii.v2i2.445

Mutia, M. S., Ginting, C. N., Yulizal, O., Suhartomi, S., & Sihotang, W. Y. (2024). Nephroprotective Effects of Sunkist Peel Ethanol Extract on Diabetic Nephropathy. Majalah Kedokteran Bandung, 56(3), 190–196.

https://doi.org/10.15395/mkb.v56.3496

Noshahr, Z. S., Salmani, H., Khajavi Rad, A., & Sahebkar, A. (2020). Animal Models of Diabetes-Associated Renal Injury. Journal of Diabetes Research, 2020, 1–16.

https://doi.org/10.1155/2020/9416419

Preeti, Sambhakar, S., Malik, R., Bhatia, S., Al Harrasi, A., Rani, C., & Sehrawat, R. (2023). Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs. Scientifica, 2023.

https://doi.org/10.1155/2023/6640103

Primadana, F. F. I., Erawati, T., Rosita, N., & Hamdan, S. H. (2024). Application of the Simplex Lattice Design Methode to Determine the Optimal Formula Nanoemulsion with Virgin Coconut Oil and Palm Oil. Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia, 11(3), 395–401.

https://doi.org/10.20473/jfiki.v11i32024.395-401

Qaz, M., Sawaf, H., Ismail, J., Qazi, H., & Vachharajani, T. (2022). Pathophysiology of Diabetic Kidney Disease. EMJ Nephrology, 102–113.

https://doi.org/10.33590/emjnephrol/22-00060

Ravaglia, F., Melica, M. E., Angelotti, M. L., De Chiara, L., Romagnani, P., & Lasagni, L. (2022). The Pathology Lesion Patterns of Podocytopathies: How and why? Frontiers in Cell and Developmental Biology, 10.

https://doi.org/10.3389/fcell.2022.838272

Samsu, N. (2021). Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed Research International, 2021, 1–17.

https://doi.org/10.1155/2021/1497449

Sari, M., Ginting, C. N., & Yulizal, O. (2021). Sunkist Peel Ethanol Extract Ameliorates Diabetic Nephropathy in Streptozotocin-Induced Diabetic Wistar Rats. Open Access Macedonian Journal of Medical Sciences, 9(A), 1086–1091.

https://doi.org/10.3889/oamjms.2021.7362

Thöni, S., Keller, F., Denicolò, S., Buchwinkler, L., & Mayer, G. (2022). Biological variation and reference change value of the estimated glomerular filtration rate in humans: A systematic review and meta-analysis. Frontiers in Medicine, 9.

https://doi.org/10.3389/fmed.2022.1009358

Uil, M., Scantlebery, A. M. L., Butter, L. M., Larsen, P. W. B., de Boer, O. J., Leemans, J. C., & Roelofs, J. J. T. H. (2018). Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain. Scientific Reports, 8(1), 5542.

https://doi.org/10.1038/s41598-018-23839-9

Wang, R., Wu, G., Dai, T., Lang, Y., Chi, Z., Yang, S., & Dong, D. (2020). Naringin attenuates renal interstitial fibrosis by regulating the TGF β/Smad signaling pathway and inflammation. Experimental and Therapeutic Medicine, 21(1), 66.

https://doi.org/10.3892/etm.2020.9498

Yusuf, B. O., Okeme, U., Akinfenwa, A. O., Moronfolu, I. A., Bisiriyu, Z. A., Lukman, H. Y., … Ibrahim, R. B. (2025). Control of diabetic nephropathy in male Wistar rats using ethanolic extract of Monodora myristica seeds and its biosynthesized selenium nanoparticles. Exploration of Drug Science.

https://doi.org/10.37349/eds.2025.100889

Za'abi, M. Al, Ali, B. H., Al Suleimani, Y., Adham, S. A., Ali, H., Manoj, P., & Nemmar, A. (2021). The Effect of Metformin in Diabetic and Non-Diabetic Rats with Experimentally-Induced Chronic Kidney Disease. Biomolecules, 11(6), 814.

https://doi.org/10.3390/biom11060814

Zhang, L., Jiang, L., Xu, R., Zhang, X., Zhang, B., & Yue, R. (2025). Epidemiological research on diabetic nephropathy at global, regional, and national levels from 1990 to 2021: an analysis derived from the global burden of disease 2021 study. Frontiers in Endocrinology, 16.

https://doi.org/10.3389/fendo.2025.1647064